Comparing Neurometrix (NURO) and Utah Medical Products (UTMD)

Neurometrix (NASDAQ: NURO) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

Volatility & Risk

Neurometrix has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500.

Insider & Institutional Ownership

14.7% of Neurometrix shares are held by institutional investors. Comparatively, 69.3% of Utah Medical Products shares are held by institutional investors. 4.5% of Neurometrix shares are held by company insiders. Comparatively, 8.8% of Utah Medical Products shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Neurometrix and Utah Medical Products’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Neurometrix -47.75% -161.28% -89.85%
Utah Medical Products 21.56% 18.94% 16.50%

Earnings and Valuation

This table compares Neurometrix and Utah Medical Products’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Neurometrix $17.09 million 0.56 -$12.85 million N/A N/A
Utah Medical Products $41.41 million 10.26 $8.50 million N/A N/A

Utah Medical Products has higher revenue and earnings than Neurometrix.

Dividends

Utah Medical Products pays an annual dividend of $1.08 per share and has a dividend yield of 0.9%. Neurometrix does not pay a dividend.

Analyst Recommendations

This is a breakdown of current recommendations for Neurometrix and Utah Medical Products, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neurometrix 0 0 1 0 3.00
Utah Medical Products 0 0 0 0 N/A

Neurometrix presently has a consensus price target of $3.00, suggesting a potential upside of 132.56%. Given Neurometrix’s higher probable upside, research analysts clearly believe Neurometrix is more favorable than Utah Medical Products.

Summary

Utah Medical Products beats Neurometrix on 10 of the 12 factors compared between the two stocks.

About Neurometrix

NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Asia, the Middle East, Mexico, and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.

About Utah Medical Products

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and UTMD supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.

Receive News & Ratings for Neurometrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neurometrix and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply